OGT - Precision genomic solutions
Accelerate your clinical trial assay and CDx development programmes in haematological malignancies by partnering with OGT’s precision medicine team Discover more
Find out about OGT
At OGT we know that behind every sample is a life that can be improved through the right care decisions. It is our goal to enable researchers and clinical decision makers worldwide to reach the …
Company information | OGT
Learn about OGT's quality assurance and social responsibility and get access to legal information including the website terms of use and privacy policy.
OGT company news
Nov 10, 2025 · Find out about the latest news from OGT, including product launches and updates, new research projects, and other major company updates.
CytoCell fluorescence in situ hybridisation (FISH) - OGT
Developed by scientists, for scientists, OGT's CytoCell ® portfolio offers a comprehensive range of over 545 FISH probes for haematology, solid tumour, cytogenetics and rare disease, supported by our …
OGT management team
OGT management team Find out a little bit about the OGT board members and executive team.
CytoCell MLL (KMT2A) Breakapart FISH Probe - OGT
Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter.
SureSeq Myeloid MRD NGS Panel - OGT
OGT specializes in the development of superior hybrid capture technology that excels in the detection of complex structural variants and eliminates inaccurate calls caused by alternative PCR-based …
Careers | OGT
Want to know why OGT is such a great place to work? Here you can discover more about the different teams that make OGT tick, including R&D, Computational Biology and Operations.
Recommended FISH protocol for CytoCell AML and MDS FISH probe …
This protocol is provided for use with the FDA-cleared range of CytoCell ® FISH probe kits for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Reference the Package Insert …